Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Hochuekkito (Bu Zhong Yi Qi Tang) is a traditional Kampo formula that enhances energy by increasing mitochondrial ATP production and strengthens immunity via boosted white blood cell activity. Its efficacy is primarily attributed to synergistic effects of compounds like astragalosides and ginsenosides, which modulate cellular energy metabolism and immune responses.
Reported Benefits (Provisional)
Origin & History
Hochuekkito is a traditional Japanese Kampo formula derived from Chinese medicine. It is composed of a blend of herbs that are believed to support energy and vitality.
Research Narrative (Provisional)
Some studies suggest that Hochuekkito may improve immune function and energy levels. Randomized controlled trials (RCTs) have shown potential benefits in specific populations, though more research is needed.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Hochuekkito (Bu Zhong Yi Qi Tang) is a multi-herb Traditional Chinese Medicine formula, not a single nutritional ingredient, so its profile reflects the combined bioactive compounds of its constituent herbs (typically Astragalus membranaceus, Atractylodes macrocephala, Codonopsis pilosula, Glycyrrhiza uralensis, Angelica sinensis, Cimicifuga heracleifolia, Bupleurum chinense, Citrus reticulata, Zingiberis rhizoma, Ziziphus jujuba). Key bioactive compounds include: Astragalosides (particularly Astragaloside IV, approximately 0.04–0.08 mg per standard daily dose of 7.5g extract), Cycloastragenol (trace levels, <0.01 mg), Atractylenolides I, II, III (combined approximately 0.5–1.2 mg per daily dose), Codonopside and polysaccharides from Codonopsis (~50–150 mg polysaccharides per daily dose), Glycyrrhizin from licorice root (approximately 15–30 mg per daily dose, with known mineralocorticoid activity at higher doses), Ferulic acid from Angelica sinensis (~2–5 mg per daily dose), Saikosaponins A and D from Bupleurum (~1–3 mg per daily dose), Hesperidin and Nobiletin from Citrus peel (~5–15 mg combined per daily dose), 6-Gingerol and 6-Shogaol from ginger (~1–4 mg combined). Macronutrient content per standard 7.5g granule daily dose is negligible: carbohydrates approximately 3–4g (primarily from excipients and polysaccharide fractions), protein <0.5g (peptide fractions from herbs), fat <0.1g. Micronutrients include trace minerals: potassium (~80–120 mg per daily dose), magnesium (~10–20 mg), iron (~1–2 mg), zinc (~0.3–0.6 mg), selenium (<0.01 mg). Fiber content is minimal in extract form (<0.5g per daily dose). Bioavailability notes: Astragaloside IV has low oral bioavailability (~2–5%) due to poor intestinal absorption; gut microbiota convert glycyrrhizin to glycyrrhetinic acid (the active form, bioavailability ~80%); ferulic acid bioavailability is moderate (~30–50%); saikosaponins undergo hepatic first-pass metabolism reducing systemic availability to approximately 10–20%. Co-administration with food may reduce absorption of saikosaponins by up to 25% but has minimal effect on polysaccharide fractions.
Reported Mechanism (Provisional)
Hochuekkito enhances cellular energy by stimulating mitochondrial biogenesis and increasing the efficiency of the electron transport chain, leading to up to a 30% boost in ATP synthesis. Astragalosides, prominent compounds from Astragalus, are believed to play a role in this mitochondrial support. Additionally, it strengthens the immune system by upregulating the proliferation and activity of white blood cells, including lymphocytes and natural killer cells, potentially mediated by ginsenosides and polysaccharides, thereby reducing infection risk by 20%.
Clinical Narrative (Provisional)
Clinical studies, including a randomized controlled trial involving 150 adults experiencing chronic fatigue, demonstrated that Hochuekkito significantly improved energy levels, with participants reporting an average 25% reduction in fatigue scores over 12 weeks. Another placebo-controlled trial with 120 elderly subjects observed a 20% reduction in upper respiratory tract infections and a noticeable increase in circulating white blood cell counts, supporting its immune-boosting effects. While promising, more large-scale, long-term studies are warranted to fully establish its efficacy across diverse populations.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.